|
Pharma cos set to gain from US nod for asthma drug
Business Standard New Delhi, Aug 5 (PTI) Indian drug makers, including Aurobindo and Glenmark, are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and allergies in the US market. Last week the US Food and … |
View full post on asthma – Google News